Results

Total Results: 543 records

Showing results for "anticoagulant prophylaxis".

101. Stroke Prevention in Atrial Fibrillation | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/stroke-atrial-fibrillation/research-protocol
     January 30, 2012 - These compounds create an anticoagulant effect by inhibiting the y-carboxylation of vitamin K-dependent … New anticoagulants are challenging the predominance of VKA for stroke prophylaxis in AF. … Am Heart J 2010;159(3):331-9 24 ) The evolution of the newer anticoagulation agents investigated in … example, in patients with AF undergoing surgery or percutaneous procedures, the duration of holding anticoagulant … Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota

102. Stroke Prevention in Atrial Fibrillation | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/stroke-atrial-fibrillation/research-protocol
     December 01, 2019 - These compounds create an anticoagulant effect by inhibiting the y-carboxylation of vitamin K-dependent … New anticoagulants are challenging the predominance of VKA for stroke prophylaxis in AF. … Am Heart J 2010;159(3):331-9 24 ) The evolution of the newer anticoagulation agents investigated … example, in patients with AF undergoing surgery or percutaneous procedures, the duration of holding anticoagulant … Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota

103. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
     January 30, 2012 - These compounds create an anticoagulant effect by inhibiting the у-carboxylation of vitamin K-dependent … New anticoagulants are challenging the predominance of VKA for stroke prophylaxis in AF. … Am Heart J 2010;159(3):331-924) The evolution of the newer anticoagulation agents investigated in … example, in patients with AF undergoing surgery or percutaneous procedures, the duration of holding anticoagulant … Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota

104. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
     January 30, 2012 - These compounds create an anticoagulant effect by inhibiting the у-carboxylation of vitamin K-dependent … New anticoagulants are challenging the predominance of VKA for stroke prophylaxis in AF. … Am Heart J 2010;159(3):331-924) The evolution of the newer anticoagulation agents investigated in … example, in patients with AF undergoing surgery or percutaneous procedures, the duration of holding anticoagulant … Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota

105. UChicago Medicine Reduces Perioperative Venous Thromboembolism with AHRQ's Toolkit | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/about/uni-chicago-medicine.html
     February 01, 2024 - The aims of the taskforce were to strengthen established chemical and mechanical prophylaxis and ambulation … concluded that the aims of the taskforce would be to strengthen established chemical and mechanical prophylaxis

106. Making Healthcare Safer III Patient Safety Practices | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/making-healthcare-safer/mhs3/practices.html
     April 01, 2020 - Carbapenem-Resistant Enterobacteriaceae  ( PDF , 1.4 MB) Contact Precautions Harms Due to Anticoagulants … Intervention TCM: Transitional Care Model Venous Thromboembolism ( PDF , 1.4 MB) Postsurgical Prophylaxis

107. Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug Events Related to Anticoagulants | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/high-risk-drugs/protocol
     September 01, 2023 - What patient safety measures or indicators have been used to examine the harm associated anticoagulant … What studies have assessed the effectiveness and unintended effects of PSPs (i.e., PSP 1 anticoagulant … treatment and prophylaxis of venous thromboembolism in patients with cancer. … : focus on new anticoagulant agents. … Harms Due to Anticoagulants.

108. Heparin: improving treatment and reducing risk of harm. | PSNet
     psnet.ahrq.gov/issue/heparin-improving-treatment-and-reducing-risk-harm
     July 28, 2021 - View More Related Resources Modes of failure in venous thromboembolism prophylaxis … February 23, 2011 Reducing anticoagulant medication adverse events and avoidable patient

109. VTE Surveillance Assessment_49_low_SPI (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
     December 01, 2012 - DVT and the scheduled anticoagulant treatment for DVT, once it was detected, may have diminished the … 1) 225 223 use cctr (0) *************************** SCOPUS: Major Line: 4 (ALL(anticoagulants … ) OR LIMIT-TO(PUBYEAR, 2012) OR LIMIT-TO(PUBYEAR, 2011)) Total: 13 -- Line: 1 ALL(anticoagulants … (LIMIT-TO(PUBYEAR, 2012) OR LIMIT-TO(PUBYEAR, 2011) OR LIMIT-TO(PUBYEAR, 2010)) 23 18 (((ALL(anticoagulants … and the scheduled anticoagulant treatment for DVT, once it was detected, may have diminished the percentage

110. VTE Surveillance Assessment_49_low_SPI (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
     December 01, 2012 - DVT and the scheduled anticoagulant treatment for DVT, once it was detected, may have diminished the … 1) 225 223 use cctr (0) *************************** SCOPUS: Major Line: 4 (ALL(anticoagulants … ) OR LIMIT-TO(PUBYEAR, 2012) OR LIMIT-TO(PUBYEAR, 2011)) Total: 13 -- Line: 1 ALL(anticoagulants … (LIMIT-TO(PUBYEAR, 2012) OR LIMIT-TO(PUBYEAR, 2011) OR LIMIT-TO(PUBYEAR, 2010)) 23 18 (((ALL(anticoagulants … and the scheduled anticoagulant treatment for DVT, once it was detected, may have diminished the percentage

111. Microsoft PowerPoint - Spotlight Case_Anesthesia Error During Cesarean_06.22.2023 - Final.pptx (pdf file)
     psnet.ahrq.gov/sites/default/files/2023-06/hurried_huddle_0.pdf
     January 01, 2023 - the last dose of LMWH.20 – By contrast, both ACOG and ACCP list LMWH as their preferred prophylactic anticoagulant … There should be discussion about which prophylactic anticoagulant may be best for each patient admitted … Each of these checklists should be adapted as needed, and review of anticoagulant name, dose, and timing … Obstetric venous thromboembolism prophylaxis: what obstetricians should know about anesthesia guidelines … Epidural hematoma following low molecular weight heparin prophylaxis and spinal anesthesia for cesarean

112. Electronic alerts to prevent venous thromboembolism among hospitalized patients. | PSNet
     psnet.ahrq.gov/issue/electronic-alerts-prevent-venous-thromboembolism-among-hospitalized-patients
     October 19, 2022 - With reported underutilization of deep-vein thrombosis (DVT) prophylaxis, this study examined the impact … software program to an existing patient database to identify patients at risk who were not receiving prophylaxis … Results demonstrated increased use of both mechanical and pharmacologic prophylaxis, as well as decreased

113. Vascular Diseases | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/vascular-diseases
     August 16, 2010 - Atherosclerotic Plaque Technical Brief Archived August 16, 2010 Venous Thromboembolism Prophylaxis … Orthopedic Surgery Systematic Review Archived March 13, 2012 Venous Thromboembolism Prophylaxis … Review Archived September 25, 2013 Systematic Review Update of Venous Thromboembolism Prophylaxis … Report January 29, 2014 Comparative Effectiveness of Venous Thromboembolism (VTE) Prophylaxis … ) Reports on Future Research Research Report June 10, 2011 Antiplatelet and Anticoagulant

114. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/50611/psn-pdf
     October 30, 2019 - was complicated by an acute pulmonary embolism (PE), which was treated with rivaroxaban (a new oral anticoagulant … Direct oral anticoagulants (such as rivaroxaban) were developed to overcome the myriad of known risks … However, there is now a risk that a physician might erroneously use it to start prophylaxis for stroke … in a patient with atrial fibrillation or at risk for DVT or pulmonary embolism (prophylaxis requires … Could his PE have been prevented had he been given DVT/PE prophylaxis in the hospital?

115. The Lost Start Date: an Unknown Risk of E-prescribing | PSNet
     psnet.ahrq.gov/web-mm/lost-start-date-unknown-risk-e-prescribing
     December 02, 2020 - was complicated by an acute pulmonary embolism (PE), which was treated with rivaroxaban (a new oral anticoagulant … Direct oral anticoagulants (such as rivaroxaban) were developed to overcome the myriad of known risks … in a patient with atrial fibrillation or at risk for DVT or pulmonary embolism (prophylaxis requires … Could his PE have been prevented had he been given DVT/PE prophylaxis in the hospital? … September 30, 2020 WebM&M Cases Direct Oral Anticoagulants

116. Operating Room Briefing and Debriefing Audit Tool | Agency for Healthcare Research and Quality
     www.ahrq.gov/hai/tools/surgery/tools/applying-cusp/or-briefing-audit.html
     December 01, 2017 -     Airway risk       Access issues       Bleeding concerns (e.g., anticoagulant …       Allergies       Glycemic control       Deep vein thrombosis prophylaxis

117. Tool: OR Briefing and Debriefing Audit Tool (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/surgery/tools/applying-cusp/or_briefing_audit.docx
     December 01, 2017 - time Beta blockers Airway risk Access issues Bleeding concerns (e.g., anticoagulant … Blood availability Allergies Glycemic control Deep vein thrombosis prophylaxis

118. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/849661/psn-pdf
     June 28, 2023 - the last dose of LMWH.20 By contrast, both ACOG and ACCP list LMWH as their preferred prophylactic anticoagulant … Second, there should be discussion about which prophylactic anticoagulant may be best for each patient … Each of these checklists should be adapted as needed, and review of anticoagulant name, dose, and timing … Obstetric venous thromboembolism prophylaxis: what obstetricians should know about anesthesia guidelines … Epidural hematoma following low molecular weight heparin prophylaxis and spinal anesthesia for cesarean

119. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
     July 27, 2023 - What are the frequency and severity of harms associated with anticoagulant use in the inpatient and … What patient safety measures or indicators have been used to examine the harm associated anticoagulant … treatment and prophylaxis of venous thromboembolism in patients with cancer. … : focus on new anticoagulant agents. … Harms Due to Anticoagulants.

120. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
     July 27, 2023 - What are the frequency and severity of harms associated with anticoagulant use in the inpatient and … What patient safety measures or indicators have been used to examine the harm associated anticoagulant … treatment and prophylaxis of venous thromboembolism in patients with cancer. … : focus on new anticoagulant agents. … Harms Due to Anticoagulants.